Evidence map›Paper›PMID 34151176›Full record

ArticleAccess microbiology2021

Parallel bioreactor system for accessible and reproducible anaerobic culture.

Taylor I Monaghan, Joseph A Baker, Gary K Robinson, Mark Shepherd

Abstract read
In one paragraph

Article in Access microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Taylor I MonaghanSchool of Biosciences, RAPID Group, University of Kent, Canterbury, CT2 7NJ, UK.
Joseph A BakerSchool of Biosciences, RAPID Group, University of Kent, Canterbury, CT2 7NJ, UK.
Gary K RobinsonSchool of Biosciences, RAPID Group, University of Kent, Canterbury, CT2 7NJ, UK.ORCID https://orcid.org/0000-0003-2660-7778
Mark ShepherdSchool of Biosciences, RAPID Group, University of Kent, Canterbury, CT2 7NJ, UK.ORCID https://orcid.org/0000-0002-7472-2300

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

When working with anaerobic bacteria it is important to have the capability to perform parallel bioreactor growth experiments that are both controllable and reproducible, although capital and consumables costs for commercially available systems are often prohibitively high. Hence, a three-vessel parallel bioreactor system was designed and constructed that has the capabilities for batch and fed batch processes and can also be set up for continuous culture at a fraction of the cost of commercial systems. This system carries over many of the same functionalities of those systems with a higher price point of entry, including in-line monitoring of temperature, pH, and redox poise. To validate the performance of this system

Indexed as

ABE fermentationanaerobicbioreactorClostridium

Identifiers

PMID34151176
PMCPMC8208757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.